Skip to main content
OpenTrials
Completed

NCT Number: NCT06066788

Cognitive Strategies for Improving Health Outcomes And Managing Risk Post-Stroke

The proposed research will further develop the CHAMPS intervention which is self-management intervention to learn new skills, despite current health status of experience a stroke. The study seeks to determine feasibility and compare pre- to post-intervention change including cardiovascular risk, quality of life, self-efficacy, recurrent stroke, hospital readmission, and perceived decline in health and function.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

UNM Health Sciences

Albuquerque, New Mexico, 87131, United States

About this study

People living with the effects of stroke frequently require assistance with everyday tasks (e.g., dressing, managing medications, driving) well-beyond 90-days post stroke. Executive function (EF) deficits are a major contributor to disability and as many as 75% of stroke survivors present with EF deficits. EF is a collection of cognitive processes that include orienting towards the future (i.e. planning), demonstrating self-control (i.e. behavioral inhibition), problem-solving, adapting to environmental changes, and facilitating goal-directed behaviors, all of which are essential skills for managing health. EF deficits are frequently undetected during hospitalization and result in discharge to the community with as many as 71% of survivors receiving inadequate services for long-term needs. Furthermore, scales of neurological impairment for classifying stroke severity like the NIH Stroke Scale (NIHSS) are frequently used as a standard of care and also sometimes support identification of impairments. However, research previously conducted by the research team indicates that this goes beyond the intended scope of the tools and scales like the NIHSS do not relate to EF deficits thus resulting in inadequate rehabilitation referrals if another EF screening or assessment is not used. Persons with post-stroke EF deficits have a multitude of modifiable risk factors that require intervention beyond regular health advice only. Consequently, the demand for specialized interventions to prevent and mitigate negative health outcomes (e.g., recurrent stroke, cardiovascular disease risk, cognitive decline risk, hospital readmission) in this population is quickly expanding and offers a significant opportunity for supporting recovery and improving quality of life for people with stroke. Although lifestyle-based vascular risk factor reduction interventions are numerous, there is a lack of consideration for targeting cognitive factors that can influence real-world application.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • primary diagnosis of acute ischemic stroke within 90 days
  • impairment of executive function (score >11 on Executive Interview)
  • absence of severe aphasia (score of 0 or 1 on NIHSS will be included)
  • absence of pre-stroke dementia (per client report)
  • absence of major depressive disorder (PHQ-9 <14, Generalized Anxiety Disorder-7)
  • absence of drug and alcohol misuse within 3 months of study admission (AUDIT)
  • access to video-conference software on computer or device like computer tablet or smart phone
  • >18 years of age

Exclusion criteria

  • Not fluent in English

Treatment and study plan

CHAMPS

Other

Cognitive Orientation to daily Occupational Performance is a performance-based treatment approach for children and adults who experience difficulties performing the skills they want to, need to or are expected to perform. Cognitive Orientation to daily Occupational Performance is a specifically tailored, active client-centered approach that engages the individual at the meta-cognitive level to solve performance problems. Focused on enabling success, the Cognitive Orientation to daily Occupational Performance Approach employs collaborative goal setting, dynamic performance analysis, cognitive strategy use, guided discovery, and enabling principles. These elements, all considered essential to the Cognitive Orientation to daily Occupational Performance Approach, are situated within a structured intervention format, and with parent/significant other involvement as appropriate.

Other names: Cognitive Orientation to daily Occupational Performance

Primary outcomes

  1. Suitability and Feasibility Survey

    Time frame: 6 months

    This survey will be conducted at the conclusion of study, to be completed by participants, examining whether this intervention is suitable and that the research protocols are feasible to be administered.

  2. Battery of American Heart Association Life's Essential 8

    Time frame: 6 months

    A battery of measures asking about the following:

    • Blood pressure
    • Weight and Height (BMI)
    • Blood sugar questions: Recently, has your doctor talked to you about managing your A1C?
    • Cholesterol, Cholesterol is a fatty substance found in the blood. About how long has it been since you last had your cholesterol checked? Have you ever been told by a doctor, nurse or other health professional that your cholesterol is high? Are you currently taking medicine prescribed by your doctor or other health professional for your cholesterol?
    • Smoking, recently, have you smoked or been around anyone who has smoked tobacco products?
    • Physical Activity, How active do you consider yourself? At least 150 minutes a week to be considered active
    • Sleep, How would you describe your sleep?
    • Diet, How would describe your diet?

Secondary outcomes

  1. NIH Stroke Scale

    Time frame: 6 months

    National Health Stroke Scale:

    15 items assessing severity of impairment in LOC, ability to respond to questions and obey simple commands, papillary response, deviation of gaze, extent of hemianopsia, facial palsy, resistance to gravity in the weaker limb, plantar reflexes, limb ataxia, sensory loss, visual neglect, dysarthria and aphasia severity.

    Items are graded on a 3- or 4-point ordinal scale; 0 means no impairment. Scores range from 0 - 42. Higher scores indicate greater severity.

    • Very Severe: >25
    • Severe: 15 - 24
    • Mild to Moderately Severe: 5 - 14
    • Mild: 1 - 5
  2. Stroke Specific Quality of Life Scale

    Time frame: 6 months

    A quality of life measure designed for stroke subjects.

    49 items Items are assessed on 5-point Guttman-type scales. Each item is answered using 1 of 3 different response sets.

    Provides both summary and domain specific scores:

    • Domain scores are composed of unweighted averages
    • Summary scores are composed of an unweighted average of the 12 domain average scores Scores range from 49-245. Higher scores indicate better functioning.

    The 12 domains include:

    • Mobility
    • Energy
    • Upper Extremity Function
    • Work and Productivity
    • Mood
    • Self-care
    • Social Roles
    • Family Roles
    • Vision
    • Language
    • Thinking
    • Personality
  3. Healthcare utilization Questionnaire

    Time frame: 6 months

    An informal questionnaire regarding unanticipated hospitalization, to be completed by participants at the end of the study.

Sponsors and collaborators

Lead sponsor

University of New Mexico

Other

Registry information

Acronym: CHAMPS

Important dates

Study start
2024
Primary completion
2024
Study completion
2024
First posted
Oct 4, 2023
Registry last updated
Sep 19, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.